Aller au contenu principal
Accès ouvert déclaré 2021 article

Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination

26Citations signalées, ce qui n’est pas une note de qualité
7Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

A multisystem infl ammatory syndrome in chil- dren (MIS-C) and adults (MIS-A) occurring after coronavirus disease (COVID-19) has been identifi ed; onset is ≈4-6 weeks after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (1-3).A case defi nition for MIS-A has been developed by the Centers for Disease Control and Prevention (CDC) (4); MIS-A after vaccination is rare and remains of great clinical and public health interest (5).We report a case study and histopathologic fi ndings from a fatal MIS-A case after SARS-CoV-2 infection and subsequent complete COVID-19 vaccination. The PatientThe patient was a healthcare worker in his 30s with no notable medical history.In December 2020, he experienced mild COVID-19-like illness symptoms, including fatigue and loss of taste and smell.He did not undergo testing for SARS-CoV-2 at that time and was unaware of the need for isolation.Six days after onset of COVID-19-like symptoms, and when fully recovered, the patient received the fi rst dose of Pfi zer/BioNTech (https://www.pfizer.com) mRNA COVID-19 vaccine.He received the second dose 20 days later.After the second dose, he reported fatigue and malaise, which resolved within 2 days.Twenty-two days after receiving the second dose of the COVID-19 vaccine, he had onset of new fever, malaise, headache, and odynophagia.He was examined by an outpatient medical provider.Diagnostic testing was notable for a negative COVID-19 test by reverse transcription PCR (RT-PCR), negative rapid infl uenza antigen, and negative rapid antigen detection for group A Streptococcus. Four days later, the patient visited an emergency department because of worsening symptoms.Assessment of vital signs revealed a temperature of 37.2°C, heart rate 113 beats/min, and blood pressure of 117/66 mmHg.Physical examination identifi ed right-sided cervical lymphadenopathy, marked bilateral conjunctival erythema, and a faint papular rash on the pelvis and left fl ank.Laboratory testing revealed a peripheral-blood leukocyte count of 11,000 cells/ µL, 93.5% segmented neutrophils, and thrombocytopenia with a platelet count of 110,000/µL (Table).Portable chest radiograph results were without notable fi ndings.On hospital day 2, the patient remained febrile and tachycardic (heart rate 90-135 beats/min) and Fatal Multisystem Infl ammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination
Date Crossref
01/11/2021
Éditeur
Centers for Disease Control and Prevention (CDC)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Kawasaki Disease and Coronary ComplicationsSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and Thrombosis

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.